Effect of Pre-emptive Transcutaneous Neuro-muscular Electrical Stimulation for Dysphagia in Long Term Intubated Patients

Overview

It was well known that long term intubation caused a various kind of abnormal presentations of dysphagia such as the increased aspiration risk, the decreased gag reflex, mucosal pathology, the airway stenosis and so on. It was thought that the freezing and impaired proprioception to be developed as a result of dis-use around the pharynx and the larynx while intubation was one of the reason. Preemptive swallowing manual stimulation applied on the oral cavity to avoid the vicious cycle of dis-use was reported to improve dysphagia after extubation. Neuromuscular electrical stimulation have been utilized for a wide variety of dysphagia of multiple causes of neuro-muscular disorder. Supposing that preemptive transcutaneous neuromuscular electrical stimulation to be delivered to the muscles of being involved in swallowing could decrease the degree of dis-use during intubation so that it could reduce the occurence and severity of dysphagia developed after extubation, the investigators plan to perform randomized prospective double blind placebo controlled clinical interventional study.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: Triple (Participant, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: September 2012

Interventions

  • Procedure: Transcutaneous neuro-muscular electrical stimulation
    • Neuro-muscular electrical stimulation with two pairs of surface electrodes was applied to submental area. One paired electrodes to be placed horizontally was attached on the anterior half of area between mandible and hyoid bone. The other was affixed to posterior half of the same area far laterally. Bipolar electrical stimulation with pulse rate of 80-Hz, duration of 700 µs and intensity to evoke visible muscle contraction was performed for 60 minutes a day until one day before extubation.

Clinical Trial Outcome Measures

Primary Measures

  • oro-pharyngeal swallowing efficiency
    • Time Frame: as soon as patient could tolerate videofluoroscopic swallowing study after extubation; average of 5 days
    • oro-pharyngeal swallowing efficiency was calculated by using the data derived from videofluoroscopic swallowing study

Secondary Measures

  • oral transit time
    • Time Frame: as soon as patient could tolerate videofluoroscopic swallowing study after extubation; average of 5 days
    • oral transit time was measured through videofluoroscopic swallowing study
  • pharyngeal transit time
    • Time Frame: as soon as patient could tolerate videofluoroscopic swallowing study after extubation; average of 5 days
    • pharyngeal transit time was measured through videofluoroscopic swallowing study
  • oro-pharyngeal transit time
    • Time Frame: as soon as patient could tolerate videofluoroscopic swallowing study after extubation; average of 5 days
    • oro-pharyneal transit time was calculated by using the data derived from videofluoroscopic swallowing study
  • swallowed volume
    • Time Frame: as soon as patient could tolerate videofluoroscopic swallowing study after extubation; average of 5 days
    • swallowd volume was measured through videofluoroscopic swallowing study
  • aspiration volume
    • Time Frame: as soon as patient could tolerate videofluoroscopic swallowing study after extubation; average of 5 days
    • aspiration volume was measured through videofluoroscopic swallowing study
  • presence of aspiration
    • Time Frame: as soon as patient could tolerate videofluoroscopic swallowing study after extubation; average of 5 days
    • presence of aspiration was checked through videofluoroscopic swallowing study
  • presence of silent aspiration
    • Time Frame: as soon as patient could tolerate videofluoroscopic swallowing study after extubation; average of 5 days
    • presence of silent aspiration was checked through videofluoroscopic swallowing study
  • penetration-aspiration scale
    • Time Frame: as soon as patient could tolerate videofluoroscopic swallowing study after extubation; average of 5 days
    • penetration-aspiration scale was scored through videofluoroscopic swallowing study

Participating in This Clinical Trial

Inclusion Criteria

  • patients to be admitted to the ICU due to the respiratory failure and intubated for at least 48 hours Exclusion Criteria:

  • Past history of intubation – Past history or current status of traumatic brain injury – Past history or current status of symptomatic stroke – Past history or current status of injury of cranial nerves – Past history or current status of neuromuscular disorder – Patient not to be expected to be extubated – Patient to reject the participation – current usage of neuro-muscular blockers

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ulsan University Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Chang Ho Hwang, Clinical Associate Professor – Ulsan University Hospital
  • Overall Official(s)
    • Chang Ho Hwang, M.D., Study Director, Ulsan University Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.